HK Stock MarketDetailed Quotes

00241 ALI HEALTH

Watchlist
  • 4.320
  • -0.120-2.70%
Market Closed Nov 8 16:08 CST
69.52BMarket Cap70.82P/E (TTM)

ALI HEALTH Key Stats

All
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2024
(Q6)Sep 30, 2023
(FY)Mar 31, 2023
(Q6)Sep 30, 2022
(FY)Mar 31, 2022
(Q6)Sep 30, 2021
(FY)Mar 31, 2021
(Q6)Sep 30, 2020
(FY)Mar 31, 2020
(Q6)Sep 30, 2019
Turnover
0.98%27.03B
12.66%12.96B
30.06%26.76B
22.90%11.5B
32.60%20.58B
30.66%9.36B
61.71%15.52B
73.97%7.16B
88.32%9.6B
119.13%4.12B
Operating income
0.98%27.03B
12.66%12.96B
30.06%26.76B
22.90%11.5B
32.60%20.58B
30.66%9.36B
61.71%15.52B
73.97%7.16B
88.32%9.6B
119.13%4.12B
Cost of sales
-0.33%-21.13B
-9.65%-10.09B
-27.88%-21.06B
-22.88%-9.2B
-38.39%-16.47B
-41.22%-7.49B
-61.59%-11.9B
-71.84%-5.3B
-95.64%-7.37B
-128.61%-3.09B
Operating expenses
-0.33%-21.13B
-9.65%-10.09B
-27.88%-21.06B
-22.88%-9.2B
-38.39%-16.47B
-41.22%-7.49B
-61.59%-11.9B
-71.84%-5.3B
-95.64%-7.37B
-128.61%-3.09B
Gross profit
3.40%5.9B
24.69%2.87B
38.79%5.7B
22.98%2.3B
13.57%4.11B
0.56%1.87B
62.11%3.62B
80.32%1.86B
67.61%2.23B
94.97%1.03B
Selling expenses
-0.45%-1.78B
-1.22%-869.38M
10.73%-1.77B
12.69%-858.89M
-62.13%-1.98B
-93.36%-983.71M
-69.08%-1.22B
-52.66%-508.74M
-58.90%-722.72M
-112.47%-333.25M
Administrative expenses
5.14%-359.98M
2.20%-169.53M
3.95%-379.49M
-1.65%-173.34M
-34.57%-395.08M
-19.25%-170.53M
-33.47%-293.6M
-36.10%-143M
-21.52%-219.97M
-22.20%-105.08M
Research and development expenses
-4.07%-705.38M
1.44%-319.31M
7.00%-677.82M
-0.38%-323.99M
-72.04%-728.83M
-40.66%-322.75M
-67.55%-423.63M
-69.79%-229.45M
-15.44%-252.84M
-30.34%-135.14M
Operating interest expense
----
27.04%-2.45M
----
-356.17%-3.36M
-55.78%-3.82M
53.35%-737K
88.85%-2.45M
91.88%-1.58M
---21.97M
-322.44%-19.46M
Special items of operating profit
9.78%-2.1B
-32.71%-1.02B
-93.21%-2.33B
-28.23%-767.49M
2.43%-1.21B
2.55%-598.52M
-27.32%-1.24B
-50.05%-614.21M
-91.24%-970.75M
-64.65%-409.34M
Operating profit
74.41%951.29M
181.96%489.46M
363.64%545.45M
184.48%173.59M
-147.06%-206.89M
-156.55%-205.48M
919.41%439.63M
1,136.28%363.34M
238.14%43.13M
141.64%29.39M
Financing cost
-2.33%-5.97M
----
---5.83M
----
----
----
----
----
----
----
Share of profits of associates
81.48%-6.97M
50.02%-9.78M
19.81%-37.6M
23.91%-19.57M
-74.59%-46.89M
22.56%-25.71M
-26.12%-26.86M
-80.30%-33.21M
-2,247.85%-21.3M
-13.21%-18.42M
Share of profit from joint venture company
-97.88%1.04M
-92.04%1.59M
3,759.81%48.98M
1,401.28%19.95M
110.98%1.27M
123.34%1.33M
9.27%-11.56M
-6.55%-5.69M
-1,628.22%-12.74M
-166.34%-5.34M
Earning before tax
70.49%939.4M
176.63%481.27M
318.20%550.99M
175.69%173.98M
-162.94%-252.51M
-170.85%-229.86M
4,311.91%401.22M
5,664.77%324.44M
114.95%9.09M
107.14%5.63M
Tax
-288.42%-56.26M
-245.19%-36.13M
-7.88%-14.49M
-513.48%-10.47M
77.06%-13.43M
96.28%-1.71M
-136.14%-58.54M
-246.13%-45.89M
19.86%-24.79M
-18.56%-13.26M
After-tax profit from continuing operations
64.61%883.14M
172.24%445.14M
301.74%536.51M
170.61%163.51M
-177.61%-265.94M
-183.13%-231.57M
2,283.23%342.68M
3,751.25%278.55M
82.90%-15.7M
91.52%-7.63M
Earning after tax
64.61%883.14M
172.24%445.14M
301.74%536.51M
170.61%163.51M
-177.61%-265.94M
-183.13%-231.57M
2,283.23%342.68M
3,751.25%278.55M
82.90%-15.7M
91.52%-7.63M
Minority profit
-139.84%-341K
-156.88%-748K
321.76%856K
547.78%1.32M
93.47%-386K
104.16%203K
35.15%-5.91M
25.28%-4.88M
7.18%-9.11M
-11.08%-6.53M
Profit attributable to shareholders
64.93%883.48M
174.91%445.89M
301.71%535.65M
169.98%162.19M
-176.18%-265.56M
-181.77%-231.77M
5,392.86%348.59M
25,819.69%283.43M
91.96%-6.59M
98.69%-1.1M
Basic earnings per share
58.44%0.0629
175.00%0.033
301.52%0.0397
169.77%0.012
-174.90%-0.0197
-179.26%-0.0172
4,483.33%0.0263
21,800.00%0.0217
91.89%-0.0006
98.75%-0.0001
Diluted earnings per share
58.33%0.0627
174.17%0.0329
301.02%0.0396
169.77%0.012
-175.19%-0.0197
-179.63%-0.0172
4,466.67%0.0262
21,700.00%0.0216
91.89%-0.0006
98.75%-0.0001
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
(FY)Mar 31, 2024(Q6)Sep 30, 2023(FY)Mar 31, 2023(Q6)Sep 30, 2022(FY)Mar 31, 2022(Q6)Sep 30, 2021(FY)Mar 31, 2021(Q6)Sep 30, 2020(FY)Mar 31, 2020(Q6)Sep 30, 2019
Turnover 0.98%27.03B12.66%12.96B30.06%26.76B22.90%11.5B32.60%20.58B30.66%9.36B61.71%15.52B73.97%7.16B88.32%9.6B119.13%4.12B
Operating income 0.98%27.03B12.66%12.96B30.06%26.76B22.90%11.5B32.60%20.58B30.66%9.36B61.71%15.52B73.97%7.16B88.32%9.6B119.13%4.12B
Cost of sales -0.33%-21.13B-9.65%-10.09B-27.88%-21.06B-22.88%-9.2B-38.39%-16.47B-41.22%-7.49B-61.59%-11.9B-71.84%-5.3B-95.64%-7.37B-128.61%-3.09B
Operating expenses -0.33%-21.13B-9.65%-10.09B-27.88%-21.06B-22.88%-9.2B-38.39%-16.47B-41.22%-7.49B-61.59%-11.9B-71.84%-5.3B-95.64%-7.37B-128.61%-3.09B
Gross profit 3.40%5.9B24.69%2.87B38.79%5.7B22.98%2.3B13.57%4.11B0.56%1.87B62.11%3.62B80.32%1.86B67.61%2.23B94.97%1.03B
Selling expenses -0.45%-1.78B-1.22%-869.38M10.73%-1.77B12.69%-858.89M-62.13%-1.98B-93.36%-983.71M-69.08%-1.22B-52.66%-508.74M-58.90%-722.72M-112.47%-333.25M
Administrative expenses 5.14%-359.98M2.20%-169.53M3.95%-379.49M-1.65%-173.34M-34.57%-395.08M-19.25%-170.53M-33.47%-293.6M-36.10%-143M-21.52%-219.97M-22.20%-105.08M
Research and development expenses -4.07%-705.38M1.44%-319.31M7.00%-677.82M-0.38%-323.99M-72.04%-728.83M-40.66%-322.75M-67.55%-423.63M-69.79%-229.45M-15.44%-252.84M-30.34%-135.14M
Operating interest expense ----27.04%-2.45M-----356.17%-3.36M-55.78%-3.82M53.35%-737K88.85%-2.45M91.88%-1.58M---21.97M-322.44%-19.46M
Special items of operating profit 9.78%-2.1B-32.71%-1.02B-93.21%-2.33B-28.23%-767.49M2.43%-1.21B2.55%-598.52M-27.32%-1.24B-50.05%-614.21M-91.24%-970.75M-64.65%-409.34M
Operating profit 74.41%951.29M181.96%489.46M363.64%545.45M184.48%173.59M-147.06%-206.89M-156.55%-205.48M919.41%439.63M1,136.28%363.34M238.14%43.13M141.64%29.39M
Financing cost -2.33%-5.97M-------5.83M----------------------------
Share of profits of associates 81.48%-6.97M50.02%-9.78M19.81%-37.6M23.91%-19.57M-74.59%-46.89M22.56%-25.71M-26.12%-26.86M-80.30%-33.21M-2,247.85%-21.3M-13.21%-18.42M
Share of profit from joint venture company -97.88%1.04M-92.04%1.59M3,759.81%48.98M1,401.28%19.95M110.98%1.27M123.34%1.33M9.27%-11.56M-6.55%-5.69M-1,628.22%-12.74M-166.34%-5.34M
Earning before tax 70.49%939.4M176.63%481.27M318.20%550.99M175.69%173.98M-162.94%-252.51M-170.85%-229.86M4,311.91%401.22M5,664.77%324.44M114.95%9.09M107.14%5.63M
Tax -288.42%-56.26M-245.19%-36.13M-7.88%-14.49M-513.48%-10.47M77.06%-13.43M96.28%-1.71M-136.14%-58.54M-246.13%-45.89M19.86%-24.79M-18.56%-13.26M
After-tax profit from continuing operations 64.61%883.14M172.24%445.14M301.74%536.51M170.61%163.51M-177.61%-265.94M-183.13%-231.57M2,283.23%342.68M3,751.25%278.55M82.90%-15.7M91.52%-7.63M
Earning after tax 64.61%883.14M172.24%445.14M301.74%536.51M170.61%163.51M-177.61%-265.94M-183.13%-231.57M2,283.23%342.68M3,751.25%278.55M82.90%-15.7M91.52%-7.63M
Minority profit -139.84%-341K-156.88%-748K321.76%856K547.78%1.32M93.47%-386K104.16%203K35.15%-5.91M25.28%-4.88M7.18%-9.11M-11.08%-6.53M
Profit attributable to shareholders 64.93%883.48M174.91%445.89M301.71%535.65M169.98%162.19M-176.18%-265.56M-181.77%-231.77M5,392.86%348.59M25,819.69%283.43M91.96%-6.59M98.69%-1.1M
Basic earnings per share 58.44%0.0629175.00%0.033301.52%0.0397169.77%0.012-174.90%-0.0197-179.26%-0.01724,483.33%0.026321,800.00%0.021791.89%-0.000698.75%-0.0001
Diluted earnings per share 58.33%0.0627174.17%0.0329301.02%0.0396169.77%0.012-175.19%-0.0197-179.63%-0.01724,466.67%0.026221,700.00%0.021691.89%-0.000698.75%-0.0001
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data